Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-site, Non-interventional, Cross-sectional Evaluation of the Caregivers' and the Physicians' Preferred Route of Administration and the Physicians' Rationale for the Choice of Neupro® in Patients With Parkinson Requiring Caregiver Support

NCT01330290 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT01330290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01330290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-site, Non-interventional, Cross-sectional Evaluation of the Caregivers' and the Physicians' Preferred Route of Administration and the Physicians' Rationale for the Choice of Neupro® in Patients With Parkinson Requiring Caregiver Support
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
August 31, 2012
Enrollment
148 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson's disease